Aex­eR­NA

Aex­eR­NA is a lipid nanoparticle startup company. The company is dedicated to developing lipid nanoparticle delivery platform technology, aiming to develop messenger ribonucleic acid (mRNA) therapies and vaccines. The company's technology utilizes a programmable and efficient lipid nanoparticle nucleic acid delivery system, including a rationally designed, low-reactivity, high-potency ionizable outer lipid library for rapid screening, as well as the aexboost lipid nanoparticle potency multiplication manufacturing process, enabling healthcare professionals to provide the optimal lipid nanoparticles for any specific therapeutic application.